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Chapter 25. Selenium in biology and human health: 
Controversies and perspectives
Vadim N. Gladyshev
Department of Biochemistry, University of Nebraska–Lincoln, Lincoln, NE 68588, USA
Summary: Important unresolved questions raised by the contributors of this book and 
addressing roles of selenium in biology and human health are discussed. Resolving 
major scientifi c controversies in the fi eld should further highlight a bright future for 
selenium in fundamental science, biotechnology and medicine.
Introduction
The chapters of this book make a compelling case for the remarkable prog-
ress in selenium research on the role of this element in biology and medicine 
in recent years. Still, many questions remain unanswered and contradictions 
unresolved. Research in these areas should provide investigators with many 
exciting years in the fi eld.
In this concluding chapter, some of the areas, which were selected by the 
contributors of this book to be important unresolved questions, are highlighted. 
Answers to these questions should lead to major advances in the fi eld. These 
unresolved issues are supplemented with topics, which may constitute impor-
tant challenges for future research or enhance applications of selenium biology 
in medicine and biotechnology.
Mechanism of selenocysteine incorporation
Recent fi ndings yielded long-sought components of the eukaryotic Sec inser-
tion machinery, the SECIS-binding protein [Chapter 6] and the Sec-specifi c 
elongation factor [Chapter 7]. Further characterization of these and other com-
ponents of the eukaryotic Sec insertion system [Chapters 2-5 and 8] should 
lead to advances in our understanding of the mechanism for Sec biosynthesis 
and insertion into polypeptide chains.
Future experiments should also reveal whether all components responsible 
for Sec insertion have now been identifi ed. One question to be resolved is the 
role of the kinase in phosphorylating serine that is attached to selenocysteine 
tRNA [Chapter 3]. The presence ofphosphoserine has long been recognized, 
but its function remains unknown. A second uncharacterized protein that may 
be specifi c for the eukaryotic Sec insertion system is the methylase that is 
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involved in the formation of mcmUm at the anticodon position in Sec tRNA. 
Eukaryotes have two Sec tRNA isoacceptors [Chapter 3] and two selenophos-
phate synthetases [Chapter 4] and future studies should reveal specifi c roles for 
each of these factors.
In the last decade, many studies in the eukaryotic system were built on classic 
experiments by Bock and his colleagues that identifi ed and characterized the 
principal components and the mechanism of Sec insertion into protein in bac-
teria [Chapter 2]. However, recent studies revealed unexpected complexities in 
composition and regulation of the eukaryotic Sec insertion system, where RNA-
based mechanisms, such as nonsense mediated decay [Chapter 8], the role of 
the SECIS element [Chapter 5], hierarchy in selenoprotein expression [Chapters 
8 and 14] and alternative splicing in selenoprotein genes, as well as multifunc-
tional protein machinery [Chapters 6 and 7] appear to play dominant roles.
Finally, it is not clear if the mechanism for Sec insertion is common to all 
systems. Bacterial Sec insertion has only been characterized in E. coli [Chapter 
2]. One limitation of this system is that E. coli has only three selenoproteins  and 
these  exhibit  extensive  sequence  homology. Characterization of the Sec inser-
tion system in other bacteria as well as in archaea should provide an answer as to 
whether the Sec insertion mechanism is general to all organisms [Chapter 2].
Selenoproteins and regulation of cellular processes
Only a few physiological processes in humans are known that are mediated 
by selenoproteins. These include activation and inactivation of thyroid hor-
mones [Chapter 16], antioxidant defense [Chapters 14 and 15], sperm matura-
tion [Chapter 22] and control of cellular redox processes [Chapters 14 and 15]. 
Prokaryotic processes involving several selenoproteins are better understood, 
but major unresolved questions also remain with respect to selenoprotein func-
tion and the specifi c role of selenium in protein [Chapter 10]. Less than a half 
of known eukaryotic selenoproteins have been characterized with respect to 
function, although ongoing studies may result in identifi cation of functions for 
several additional selenoproteins [Chapters 9 and 11-14]. Identifi cation and 
functional characterization of new selenoproteins will also reveal other pro-
cesses in which selenoproteins are involved. Future research may extensively 
use functional genomics approaches, such as cDNA microarrays, to reveal a 
global picture of selenium regulation.
Human selenoproteome
Currently, the number of known vertebrate selenoproteins is 22 [Chapter 9]. 
With the completion of the sequencing of the human genome, it should be 
possible to identify, in the near future, the majority, if not all, human sele-
noproteins through a combination of bioinformatics and functional genomics 
approaches. This goal is complicated by the fact that no reliable tools exist 
that identify selenoprotein genes because currently available programs recog-
nize Sec-encoding TGA codons as stop signals. However, recently developed 
bioinformatics tools that analyze SECIS elements and homologies between 
selenoproteins and their homologs should be very useful in identifying seleno-
protein genes [Chapter 9]. In addition to the human genome, all or the major-
ity of selenoprotein genes may soon be identifi ed in several other eukaryotic 
genomes, such as rats, mice and zebrafi sh. These approaches will also be use-
ful to determine how widespread is the use of selenocysteine in organisms on 
earth. Although selenoproteins were found in the three major domains of life 
(e.g., bacteria, archaea and eukaryotes), certain representatives of these organ-
isms lack selenoproteins.
Mechanism of cancer prevention by selenium
The landmark study by Clark et al. provided strong support for the cancer 
chemoprevention effect of dietary selenium and is consistent with the majority 
of epidemiological and animal studies [Chapter 17]. Nevertheless, available 
data do not justify the use selenium as a cancer preventive supplement in the 
human population. Clearly, additional studies are necessary to support the con-
clusion that supplementation of the diet with selenium decreases the incidence 
of human cancers, and to determine which cancers are prevented by this trace 
element and to what extent.
Future clinical trials will be assisted tremendously if the mechanism for cancer 
prevention by selenium is known. The lack of information on the mechanism ap-
pears to be the major drawback for further advances in this area. A current view 
on how selenium prevents cancer implicates low molecular weight selenium 
compounds in the chemoprevention effect of selenium [Chapters 17 and 23]. The 
argument in favor of this hypothesis is that cancers are best prevented by sele-
nium concentrations greatly exceeding those needed for maximal expression of 
glutathione peroxidases 1 and 3. These enzymes are chosen as markers because 
they located at the bottom of the selenoprotein hierarchy and their expression is 
thought to be consistent with the selenium status of an organism [Chapter 24].
However, evidence also emerges for the role of selenoproteins in cancer pre-
vention [Chapters 13 and 17]. For example, the recently identifi ed 15 kDa 
selenoprotein may be one of the proteins involved in this process. Its expres-
sion is changed in cancers relative to normal tissues, its gene is located in a 
chromosomal region that encodes a possible tumor suppressor gene, and the 
selenoprotein has polymorphisms that affect expression of the protein in an 
allele- and selenium-dependent manner [Chapter 13].
Questions also remain as to whether glutathione peroxidases 1 and 3 best 
illustrate selenium requirements under environmental and genetic stresses. It 
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is possible that in some individuals, who genetically predisposed to cancer, 
requirements for selenium differ from those in the normal human population.
Selenium and human diseases other than cancer
The role of selenium in etiology of several diseases has been established and 
the number of disorders, in which selenium is implicated, has steadily expand-
ed over the past decade. As reviewed in this book, selenium is involved or im-
plicated in Keshan and Kashin-Beck diseases [Chapter 18], viral suppression 
[Chapter 19], HIV infection [Chapter 20], aging, immune function [Chapter 
21], male reproduction [Chapter 22] and other disorders and pathophysiologi-
cal conditions [Chapter 18]. However, molecular mechanisms for these effects 
remain largely unknown. Further research should defi ne the mechanisms and 
identify other biomedical areas in which dietary selenium is involved.
Selenium nutritional levels in a general population versus individual-
specifi c requirements
The chemopreventive mechanistic considerations appear to be linked to a 
more general question of whether selenium requirements in the general human 
population can be adapted to satisfy specifi c ethnic, age and genetic needs of 
groups of individuals or even needs of a single individual. With the ongoing 
advances in cDNA microarrays, microchips and parallel genomic sequencing, 
information on the genetic make-up of an individual is not out of reach in the 
next decade or so. It is possible that the use of these new technologies will lead 
to determination of individual requirements for dietary selenium.
Applications of selenium in biotechnology
Recent discoveries of new selenoproteins [Chapter 9], characterization of reac-
tion mechanisms and properties of selenoproteins [Chapter 10] and advances 
in the mechanism of selenocysteine incorporation [Chapters 5-7] may lead to 
various biotechnological applications. Selenium in the form of selenomethio-
nine is already extensively used in x-ray crystallography in solving the phasing 
problem. The targeted incorporation of selenium into proteins has also been 
used occasionally for protein characterization, but technically was diffi cult to 
achieve. The fi nding that effi ciency of selenocysteine incorporation is higher 
than previously thought and that it may be regulated by adjusting levels of 
components of the selenocysteine insertion machinery [Chapters 6-8] may al-
low expression of high levels of proteins containing selenocysteine at a spe-
cifi c place in the sequence. These proteins may then be characterized in vivo in 
cell culture or animal models or in vitro mechanistically and spectroscopically. 
In particular, this method should be useful to evaluate functions of specifi c cys-
teine residues. Cysteine and selenocysteine differ by a single chalcogen atom 
and exhibit similar chemical properties. Nevertheless, nucleophilicity and re-
dox properties of selenocysteine differentiate this residue from cysteine and 
thus provide unique opportunities for functional characterization.
